BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-17 5:07 pm Unchanged | 2024-05-15 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BIOTECHNOLOGY VALUE FUND L P | 257,622 19.500% | 0 (Unchanged) | Filing |
| 2024-05-17 5:07 pm Purchase | 2024-05-15 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BIOTECHNOLOGY VALUE FUND L P | 257,622 19.500% | 257,622 (New Position) | Filing |